2015
DOI: 10.1590/s1984-82502015000400019
|View full text |Cite
|
Sign up to set email alerts
|

Convergent synthesis of new N -substituted 2-{[5-(1H -indol-3-ylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetamides as suitable therapeutic agents

Abstract: A series of N-substituted 2-{[5-(1H-indol-3-ylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetamides (8a-w) was synthesized in three steps. The first step involved the sequential conversion of 2-(1H-indol-3-yl) acetic acid (1) to ester (2) followed by hydrazide (3) formation and finally cyclization in the presence of CS 2 and alcoholic KOH yielded 5-(1H-indole-3-yl-methyl)-1,3,4-oxadiazole-2-thiol (4). In the second step, aryl/aralkyl amines (5a-w) were reacted with 2-bromoacetyl bromide (6) in basic medium to yield… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 24 publications
0
7
0
Order By: Relevance
“…The indole–1,3,4‐oxadiazole hybrid 48 (Figure 8; MIC: 9.15–12.22 μg/ml) showed potential activity against B. subtilis , S. aureus , S. typhi , E. coli , and P. aeruginosa , and the activity was slightly lower than that of ciprofloxacin (MIC: 7.29–8.54 μg/ml). [ 108 ] The 1,2,4‐triazole‐tethered indole–1,3,4‐oxadiazole hybrid 49 (MIC: 1.0–16 μg/ml) was comparable to amoxicillin (MIC: 2–16 μg/ml) against S. aureus , B. subtilis , E. coli , and P. aeruginosa , so this hybrid is a promising antibacterial compound for further study. [ 109 ] Further study revealed that the replacement of the 1,2,4‐triazole linker by 1,3,4‐oxadiazole could not improve the activity.…”
Section: Indole/isatin–azole Hybridsmentioning
confidence: 99%
“…The indole–1,3,4‐oxadiazole hybrid 48 (Figure 8; MIC: 9.15–12.22 μg/ml) showed potential activity against B. subtilis , S. aureus , S. typhi , E. coli , and P. aeruginosa , and the activity was slightly lower than that of ciprofloxacin (MIC: 7.29–8.54 μg/ml). [ 108 ] The 1,2,4‐triazole‐tethered indole–1,3,4‐oxadiazole hybrid 49 (MIC: 1.0–16 μg/ml) was comparable to amoxicillin (MIC: 2–16 μg/ml) against S. aureus , B. subtilis , E. coli , and P. aeruginosa , so this hybrid is a promising antibacterial compound for further study. [ 109 ] Further study revealed that the replacement of the 1,2,4‐triazole linker by 1,3,4‐oxadiazole could not improve the activity.…”
Section: Indole/isatin–azole Hybridsmentioning
confidence: 99%
“…Hemolytic activity of the samples was studied by the method used by (Rubab et al, 2015) Three millimeter human red blood cells were collected from Department of Clinical Medicine and Surgery, University of Agriculture, Faisalabad, Pakistan. Blood centrifuged for 5 min at 1000 ×g plasma was discarded and cells were washed with thrice witha5 mL ofachilled (4 o C) sterile isotoniccPhosphate-buffered saline (PBS) pH 7.4.…”
Section: Hemolytic Activityimentioning
confidence: 99%
“…α-Glucosidase is a membrane-bound enzyme at the epithelium of the small intestine and hydrolyzes terminal nonreducing 1–4 linked α-glucose residues to release monomeric glucose molecules, which is mainly responsible for causing hyperglycemia . The inhibition of α-glucosidase can delay the carbohydrate absorption and has been used as one of the therapeutic approaches for the treatment of diabetes. , Therefore, design and synthesis of small hybrid molecules as α-glucosidase inhibitors is an important research area in medicinal chemistry …”
Section: Introductionmentioning
confidence: 99%